Why you should attend:
- Opportunity to connect with leaders in government, health policy, academia, pharmaceutical industry, patient organizations, and contract research organizations.
- Qualify for reduced conference registration fee and travel bursary.
HIGHLIGHTS OF THE PROGRAM:
Sunday Oct. 22, 2017 @ 1–5PM (open to all registrants at no additional fee)
Pre-Conference Workshop on Precision Health – Hosted Jointly by CAPT & IHE
- This workshop will evaluate what gaps currently exist in the Canadian healthcare system and how this is
impacting patients. The workshop also aims to profile international case studies and how other jurisdictions are
embracing data and technology changes to move to a more individualized treatment approach.
Monday Oct. 23, 2017 starting at 9AM
Skating to Where the Puck is Going: How HTA and Regulatory Processes Can Be Aligned
- This session seeks to address the challenges associated with oncology products at the regulatory and
Methods for Engaging Patients in Research, Harnessing the Power of Health Data to Improve the Patient Experience
- The objective of the session is to identify the current state of health data utilization to improve patient experience
and identify future directions in the used of health data, as well as barriers to harnessing health data.
The Impact of Patient Input in HTA and Decision Making in Oncology
- The objective of this session is to share the patient experience in providing input into the pCODR process and educate the audience on how it impacts pCODR recommendations and decision making in oncology.
Tuesday Oct. 24, 2017 starting at 7AM
Breakfast Workshop (7:00-8:30AM) on Updates to Novel Methods to Control for Unmeasured Confounding by CAN-AIM/CNODES (fee of $50.00 + $6.50 HST)
Critical Review of Patient Engagement in HTA
This session will consist of speakers comparing and contrasting the engagement of patients in terms of pCODR and CDR practices; highlighting its importance, the processes involved and identifying opportunities of improvement.
Patient Oriented Research: Successes, Challenges, and Myths
This session will provide examples of integrating and engaging patients within research programs.
Bringing Patient-Centricity to Diabetes Medication Access in Canada
Canada faces a burgeoning epidemic of type II diabetes, and needs to move from “behind the 8-ball” to “ahead of the curve”. This will require holistic and proactive solutions and improving access to medications and a
personalized approached are some of the tools for getting there.
Perspectives from Ontario’s Patient Ombudsman
Christine Elliot and her fellow panelists will provide their closing remarks during this session.